Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
Public ClinicalTrials.gov record NCT05119920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Signs and Symptoms of Dry Eye Disease
Study identification
- NCT ID
- NCT05119920
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Glaukos Corporation
- Industry
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Interventions
- Pilocarpine Ophthalmic Topical Cream, Dose 1 Drug
- Pilocarpine Ophthalmic Topical Cream, Dose 2 Drug
- Pilocarpine Ophthalmic Topical Cream, Dose 3 Drug
- Placebo Ophthalmic Topical Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2022
- Primary completion
- Jul 26, 2022
- Completion
- Jul 26, 2022
- Last update posted
- Jul 11, 2023
2022
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Glaukos Investigator | Chandler | Arizona | 85224 | — |
| Glaukos Investigator | Sun City | Arizona | 85351 | — |
| Glaukos Investigator | Glendale | California | 91204 | — |
| Glaukos Investigator | Mission Hills | California | 91345 | — |
| Glaukos Investigator | Newport Beach | California | 92663 | — |
| Glaukos Investigator | Petaluma | California | 94954 | — |
| Glaukos Investigator | Rancho Cordova | California | 95670 | — |
| Glaukos Investigator | Grand Junction | Colorado | 81501 | — |
| Glaukos Investigator | Fort Myers | Florida | 33901 | — |
| Glaukos Investigator | Roswell | Georgia | 30076 | — |
| Glaukos Investigator | St Louis | Missouri | 63131 | — |
| Glaukos Investigator | Henderson | Nevada | 89052 | — |
| Glaukos Investigator | Rochester | New York | 14618 | — |
| Glaukos Investigator | Cranberry Township | Pennsylvania | 16066 | — |
| Glaukos Investigator | Memphis | Tennessee | 38119 | — |
| Glaukos Investigator | Nashville | Tennessee | 37215 | — |
| Glaukos Investigator | Houston | Texas | 77025 | — |
| Glaukos Investigator | San Antonio | Texas | 78229 | — |
| Glaukos Investigator | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05119920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05119920 live on ClinicalTrials.gov.